Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use

Míreanna comhchosúla

• Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
  de réir: Sarayut Lahnwong, et al.
  Foilsithe / Cruthaithe: (2018-07-01)
• Sodium–glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review
  de réir: Magdalena Kłusek, et al.
  Foilsithe / Cruthaithe: (2024-07-01)
• Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature
  de réir: Alexis Diaz-Ramos, et al.
  Foilsithe / Cruthaithe: (2019-09-01)
• Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure
  de réir: Dominik Kurczyński, et al.
  Foilsithe / Cruthaithe: (2022-07-01)
• Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
  de réir: Annamaria Mascolo, et al.
  Foilsithe / Cruthaithe: (2022-09-01)